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Conclusion Mucinous carcinoma does not need to be 
classified as a separate histological type from ordinary dif-
ferentiated adenocarcinoma.
Keywords Colon cancer · Mucinous carcinoma · 
Mucinous component · Histological type
Introduction
The tumor node metastasis (TMN) classification (7th edi-
tion, American Joint Committee on Cancer) classifies colo-
rectal adenocarcinoma into four histopathological grades: 
grade 1, well-differentiated adenocarcinoma; grade 2, mod-
erately differentiated adenocarcinoma; grade 3, poorly dif-
ferentiated adenocarcinoma, and grade 4, undifferentiated 
adenocarcinoma. There is no independent classification for 
colloid carcinoma or mucinous carcinoma. However, muci-
nous carcinoma or colloid carcinoma, and signet ring cell 
carcinoma are sometimes classified as independent histo-
logical entities [1–3].
There are currently no established definitions or diag-
nostic criteria for mucinous carcinoma. For example, a 
diagnosis of mucinous carcinoma required an MC area 
ratio of more than 60 % on largest cross sections of tumors 
in the studies by Symonds et al. and Umpleby et al. [4, 5]. 
However, mucinous carcinoma was defined as carcinoma 
with >50 % of tumor volume showing extracellular mucin 
in another study [6]. In the WHO classification, muci-
nous carcinoma is defined as an adenocarcinoma in which 
>50 % of the lesion is composed of pools of extracellular 
mucin [7]. Hogan et al. recently reported that mucinous 
adenocarcinoma defined according to the WHO criteria 
was associated with a reduced risk of death and better sur-
vival than non-mucinous adenocarcinoma [8]. However, the 
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oncological outcomes reported were not consistent. Some 
studies reported that an MC area ratio of 10 % or higher 
was associated with poor survival [9]. Others reported that 
the outcomes of patients with mucinous tumors were simi-
lar to those of patients with other histological tumor types 
[10].
The criteria proposed in Japan classify the histological 
type on the basis of the most dominant histological appear-
ance [11]. These criteria classify colorectal adenocarci-
noma into well-differentiated adenocarcinoma, moderately 
differentiated adenocarcinoma, poorly differentiated adeno-
carcinoma, mucinous carcinoma, and signet ring cell carci-
noma. With regard to the histological type, about 10 % of 
colon cancer patients had mucinous carcinoma. Signet ring 
cell carcinoma is exceedingly rare, its incidence was 1 % 
or lower in previous reports [2, 3, 12]. The grading of these 
lesions is determined by the content and appearance of the 
glandular structures. Therefore, the frequencies of low-
grade tumors were 70–77 % in classical adenocarcinoma, 
55–70 % in mucinous carcinoma, and 7–10 % in signet 
ring cell carcinoma [2, 3, 12].
In the present study, we examined the relationship 
between the proportion of extracellular mucin [mucinous 
components (MC)] in colon cancer tissue to the oncologi-
cal outcomes to determine whether mucinous carcinoma 
should be classified as an independent histological type of 
colon cancer.
Methods
The subjects were 1038 patients who underwent surgery 
for primary colon cancer at Tokai University Hospital 
between January 1991 and December 2005. Patients with 
appendiceal cancer were excluded. Data from the prospec-
tively maintained database of the Departments of Surgery 
and Pathology of Tokai University Hospital were reviewed.
The following clinical variables were studied: age, sex, 
tumor site, TNM stage, the administration of postoperative 
adjuvant chemotherapy, and the survival rates. For histo-
pathological evaluations, tissue specimens were stained 
with hematoxylin and eosin, and the predominant histo-
logical type, the presence or absence of MC on the largest 
cross sections of tumors, and the ratio of the area of MC 
to that of the entire tumor (MC area ratio) were evaluated. 
The MC area ratios were separately evaluated by two phy-
sicians (YM and SS), and the mean value was adopted. If 
the difference in estimated values was 20 % or greater, the 
two physicians reassessed the specimens to determine the 
consensus MC area ratio.
Because colon cancers in which MC accounts for more 
than 50 % of the cancer tissue are classified as mucinous 
carcinomas by the WHO, the tumors were classified into 
three groups according to the MC area ratio: Group 1 (MC 
area ratio, 0 %), Group 2 (1–49 %), and Group 3 (≥50 %).
The statistical analyses were performed with the Chi-
square test and Fisher’s exact test. A multivariate analysis 
was performed using a Cox proportional hazards model. 
Cumulative survival rates were calculated by the Kaplan–
Meier method and were compared with the use of log-rank 
tests.
This study was approved by the institutional review 
board of our university (14R-015).
Results
The demographic characteristics of the patients are shown 
in Table 1. The cecum, ascending colon, and transverse 
colon were defined as the right side of the colon, and the 
descending colon, sigmoid colon, and the rectosigmoid 
colon were defined as the left side of the colon. Overall, 
422 patients had right-sided colon cancer, and 616 had 
left-sided colon cancer. The histological type was well-dif-
ferentiated adenocarcinoma or moderately differentiated 
adenocarcinoma in 93 % of the patients, poorly differenti-
ated adenocarcinoma in 2 %, and mucinous carcinoma in 
4 %.
Table 1  Patient demographics and clinical characteristics
Sex (male/female) 624/414
Age (years, mean ± SD) 65 ± 12
Site
 Right sided 422 (41 %)
 Left sided 616 (59 %)
Histological type
 Well differentiated 557 (53 %)
 Moderately differentiated 413 (40 %)
 Poorly differentiated 26 (2 %)
 Mucinous 38 (4 %)
 Signet ring cell 4 (0.4 %)
Histological grade
 Grade 1 557 (53 %)
 Grade 2 419 (40 %)
 Grade 3 62 (6 %)
TNM stage
 I 105 (10 %)
 II 404 (39 %)
 III 312 (30 %)
 IV 217 (21 %)
Adjuvant chemotherapy (patients with Stage II/III)
 Administered 397 (55 %)
 Not administered 282 (39 %)
 Unknown 37 (5 %)
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Curative resection was performed in all 716 patients 
with stage II or III disease. Among these patients, 397 
(55 %) received postoperative adjuvant chemotherapy 
with an oral fluoropyrimidine, intravenous 5-fluorouracil 
plus leucovorin or, oral UFT plus leucovorin. Postopera-
tive adjuvant chemotherapy was not given to 282 patients 
(39 %), and the status of postoperative adjuvant chemother-
apy was unknown in 37 patients (5 %).
The proportions of MC are shown in Table 2. MC 
was not found in 877 patients (84 %) and was present to 
some degree in the other 161 patients (16 %). There was 
no consistent trend in the distribution of the 161 patients 
according to the MC area ratio (data not shown). The mean 
age did not differ among the three groups classified accord-
ing to the MC area ratio. The tumor size was significantly 
larger in Group 3 than in the other groups. The proportion 
of patients with right-sided colon cancer increased signifi-
cantly in parallel with the increase in the MC area ratio. In 
Group 3, the proportion of patients with advanced-stage 
disease was significantly higher than that in Group 1, but 
did not differ from that in Group 2.–
The results of a univariate analysis of the relationships 
between various factors and the survival rates in patients 
with stage II or III disease are shown in Table 3. Stage 
Table 2  Patient and tumor characteristics according to MC area ratio
MC area ratio cases (%) Group 1 Group 2 Group 3 Group 1 vs. Group 2 Group 2 vs. Group 3 Group 1 vs. Group 3
0 % 1–49 % ≧50 % P value P value P value
877 (84) 123 (12) 38 (4)
Age 64.4 ± 11.9 65.0 ± 13.6 64.3 ± 16.4 0.67 0.82 0.96
Size (cm) 5.0 ± 3.8 5.1 ± 2.2 7.2 ± 2.5 0.60 <0.0001 <0.0001
Site
Right/left 333/544 62/61 27/11 0.01 <0.0001 0.04
Stage
 I 96 9 0 0.29 0.19 0.01
 II 336 50 18
 III 272 33 7
 IV 173 31 13
Table 3  The results of a univariate analysis of factors associated with survival (patients with Stage II/III disease)
Cases            3-year OS(%)           5-year OS(%)            p value  
Sex
male    430    82        72        0.90 
female    286    80        74  
Site
right-sided   290    82        69        0.10 
left-sided   426    81        75             
Stage
    404    87        80      <0.0001  
    312    75        65 
Histological type
well differentiated  395    84         76   
moderately differentiated 279    81        70      p=0.004  
poorly differentiated  15     43        43      p=0.003            
mucinous   25    86        86 
 signet ring cell   2 
Histological grade
grade 1    395    84        76      p=0.21      p=0.16 
grade 2    285    82        71      p=0.36 
grade 3    36    63        63 
MC area ratio 
Group 1 0%    608    82        73      p=0.25      p=0.19       
Group 2 1-49%   83    82        67      p=0.08 
Group 3 50%    25    82        82 
Adjuvant chemotherapy
administered   398    86        79       0.0003 
not administered  282    78        68 
ΙΙ
ΙΙΙ
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III disease, poorly differentiated adenocarcinoma, and no 
adjuvant chemotherapy were poor prognostic factors. There 
was no significant difference in the survival among patients 
with different histological grades.
We also compared the survival rates in 716 patients 
according to the MC area ratios based on the following val-
ues: 10, 20, 30, and 50 %. There was no significant differ-
ence in the survival rates in any of the groups stratified by 
these values. The MC area ratio was not a significant deter-
minant of the oncological outcomes.
The factors that were significantly related to survival or 
showed a trend toward being significantly related to sur-
vival were included in a multivariate logistic-regression 
model. The multivariate analysis showed that stage III dis-
ease, poorly differentiated adenocarcinoma, and postopera-
tive adjuvant chemotherapy were significant prognostic fac-
tors (Table 4). The patterns of initial recurrence in patients 
with stage II or III disease are shown according to the MC 
area ratio in Table 5. There was no relationship between the 
MC area ratio and the recurrence pattern.
Discussion
Mucinous carcinoma is a histological subtype of colorec-
tal cancer in which the MC component accounts for ≥50 % 
of the overall tumor volume [13]. Well-differentiated and 
moderately differentiated adenocarcinomas are the most 
common histological types of colorectal cancer. Mucinous 
carcinoma is relatively rare. The incidence of mucinous 
carcinoma was reported to be 10 % by Kang et al. 10 % by 
Hyngstrom et al. 11 % by Nitche et al. 15 % by Symonds 
et al. 11 % by Umpleby et al. and 6 % in Japan, suggesting 
that the incidence is lower in Japan than that in the Western 
countries [2–4, 12, 14–16]. However, this difference is at 
least partially attributable to the fact that the definition of, 
and diagnostic criteria for, mucinous carcinoma differs 
between Japan and Western countries.
Mucous areas were reported to be found in the tumor 
tissue in 30 or 31 % of patients with colorectal cancer. The 
intermingling of MC in tumor tissue is not rare in well-dif-
ferentiated adenocarcinoma, moderately differentiated ade-
nocarcinoma, or poorly differentiated adenocarcinoma [9, 
10]. However, there are no established diagnostic criteria for 
mucinous carcinoma, and the criteria used in the previous 
studies have varied among investigators [1]. In our study, the 
rate of mucinous carcinoma was 4 %, which is generally con-
sistent with that reported from other hospitals in Japan [17].
The histological grading was performed based on the 
content and appearance of the glandular structures. In the 
present study, signet ring cell carcinoma was excluded 
from the analysis, because the incidence of signet ring cell 
carcinoma was 1 % or less, and pure signet ring cell carci-
noma is extremely rare. However, Sung et al. reported that 
17 % of mucinous carcinomas included some extent of sig-
net ring cells in the tumor tissue [6].
Some studies have reported that the incidence of muci-
nous carcinoma is higher in younger patients, whereas oth-
ers have found no age-related difference [2, 5, 15, 18–20]. 
Consistent results have yet to be obtained. In our series, 
there was no relationship between age and the MC area 
ratio.
Compared with well-differentiated and moderately dif-
ferentiated adenocarcinomas, mucinous carcinoma has 
been reported to develop more often in the right side of the 
colon [2, 4, 10, 15, 16, 21, 22]. In our series, an increase in 
the MC area ratio was associated with a higher proportion 
of right-sided tumors (**p < 0.0001).
Table 4  The results of a 
multivariate analysis of factors 
associated with the overall 
survival (patients with Stage II/
III disease)
Factor HR (95 % CI) P value
Right sided (right sided vs. left sided) 0.80 (0.60–1.07) 0.13
Stage III (Stage III vs. Stage II) 1.88 (1.40–2.51) 0.001
Poorly differentiated(poorly vs. well/moderately, mucinous) 5.19 (1.55–17.3) 0.007
Adjuvant chemotherapy (administered vs. not administered) 0.57 (0.43–0.77) 0.001
Table 5  Patterns of recurrence according to the MC area ratio in patients with Stage II/III disease
MC area ratio Group 1 Group 2 Group 3 Group 1 vs. Group 2 Group 2 vs. Group 3 Group 1 vs. Group 3
0 % 1–49 % ≧50 %
Patients (%) 609 (85) 83 (12) 25 (3) P value P value P value
Liver 73 10 1 1.00 0.37 0.43
Lung 31 5 0 0.92 0.49 0.48
Peritoneum 30 6 1 0.53 1.00 0.91
Lymph node 19 3 2 1.00 0.44 0.71
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Mucinous carcinoma has been reported to be associated 
with a large tumor diameter (15). In our study, an MC area 
ratio of 50 % or higher was associated with a significantly 
larger tumor size than an MC area ratio of less than 50 %. 
With regard to the sites of recurrence, mucinous carcinoma 
has been reported to have a high incidence of peritoneal 
metastasis and a low incidence of liver metastasis [14, 15, 
21, 23, 24]. In our series, however, there was no relation-
ship between the MC area ratio and recurrence pattern.
A multivariate analysis revealed that postoperative adju-
vant chemotherapy was a significant prognostic factor. 
The indications for adjuvant chemotherapy and the treat-
ment regimens were decided by the attending physicians 
at the participating hospitals during the study period. The 
presence of a mucinous component was not a criterion for 
selecting adjuvant chemotherapy.
In patients with stage II or III colon cancer who under-
went curative resection, a histological type of poorly dif-
ferentiated adenocarcinoma was a poor prognostic factor. 
Consistent results have not been obtained for the outcomes 
of mucinous carcinoma, with some studies reporting that an 
MC area ratio of 10 % or higher was associated with poor 
survival, and another reporting that the outcomes were bet-
ter, and others reporting that outcomes were similar to those 
of other histological types [8–10]. Kang et al. analyzed data 
from a database of the Surveillance, Epidemiology, and End 
Results Program of the National Cancer Institute from 1991 
through 2000 and found that the outcomes of mucinous car-
cinoma were similar to those of adenocarcinoma [2]. In our 
study, the three-year survival rates of patients with well-dif-
ferentiated and moderately differentiated adenocarcinomas 
were 84 and 81 %, respectively, similar to that, i.e., 82 % in 
Group 3 with an MC area ratio of 50 % or higher. Umpleby 
et al. classified patients into a high mucinous group, with an 
MC area ratio of higher than 80 %, and a moderate muci-
nous group, with an MC area ratio of 60–80 % [14]. The 
outcomes were poorer in the high mucinous group in that 
study. In the present study, we compared the survival rates 
according to the MC area ratios at the borderline values of 
10, 20, 30, and 50 %. However, there was no difference in 
the survival rates in any of these values.
A small number of patients have marked mucinous com-
ponents in cancer tissue, although this histological feature 
was not associated with the oncological outcomes in the 
present study. It might be best to record this histological 
feature as another histological subtype, rather than a com-
pletely separate histological type.
Conclusions
In patients with adenocarcinoma of the colon, poorly dif-
ferentiated adenocarcinoma is a significant predictor of 
poor outcomes, whereas the MC area ratio is not a signifi-
cant prognostic factor. Our results suggest that mucinous 
carcinoma histologically characterized by a preponderance 
of MC does not need to be classified as a separate histo-
logical type from ordinary differentiated adenocarcinoma.
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